Literature DB >> 8115614

Granulocytic sarcoma in childhood leukemia: imaging features.

M H Pui1, B D Fletcher, J W Langston.   

Abstract

PURPOSE: To assess imaging features of granulocytic sarcoma (GS) in children with myelogenous leukemia.
MATERIALS AND METHODS: Retrospectively analyzed were radiographs, bone scintigrams, ultrasound (US) scans, computed tomography (CT) scans, and magnetic resonance (MR) images obtained in 30 patients with acute and one with chronic myelogenous leukemia.
RESULTS: With one exception in which GS antedated leukemia, GS was present concurrently with onset of leukemia or during remission or relapse. Radiographs, nuclear studies, and US findings were nonspecific. One parascapular GS was hyperintense on T2-weighted MR images, but in all eight central nervous system studies, tumors were isointense to gray matter, muscle, or marrow on T1-weighted images and to white matter or muscle, marrow, or both on T2-weighted images. Contrast enhancement of GS was homogenous on cranial CT scans and all MR studies.
CONCLUSION: CT and MR imaging features may allow distinction of GS from hematomas and abscesses, which are also complications of leukemia. Thus, biopsy may be avoided in some patients.

Entities:  

Mesh:

Year:  1994        PMID: 8115614     DOI: 10.1148/radiology.190.3.8115614

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  49 in total

1.  Orbital granulocytic sarcoma in acute myelogenous leukemia.

Authors:  B N Lakhkar; S Banavali; P Philip
Journal:  Indian J Pediatr       Date:  2000-03       Impact factor: 1.967

2.  Isolated recurrence of intracranial granulocytic sarcoma mimicking a falx meningioma in acute myeloblastic leukemia.

Authors:  Won Ho Cho; Young Jin Choi; Byung Kwan Choi; Seung Heon Cha
Journal:  J Korean Neurosurg Soc       Date:  2010-05-31

3.  Repeated donor lymphocyte infusions overcome a myeloid sarcoma of the stomach resulting from a relapse of acute myeloid leukemia after allogeneic cell transplantation in long-term survival of more than 10 years.

Authors:  Akinori Wada; Naoki Kobayashi; Shinsuke Asanuma; Satomi Matsuoka; Mizuha Kosugi; Shiro Fujii; Shinsuke Noguchi; Takayoshi Miyazono; Masanobu Nakata; Shuichi Ota; Kiyotoshi Imai; Teiichi Hirano; Masahiro Ogasawara; Yoshio Kiyama; Masaharu Kasai
Journal:  Int J Hematol       Date:  2010-12-23       Impact factor: 2.490

4.  Granulocytic sarcoma.

Authors:  J B Ghosh; Mahua Roy; Anirban Halder
Journal:  Indian J Pediatr       Date:  2009-04-23       Impact factor: 1.967

5.  Primary granulocytic sarcoma of ovary.

Authors:  Priyankur Roy; Bivas Biswas; Siva Sankari; Marie Therese Manipadam; Ruby Jose
Journal:  J Obstet Gynaecol India       Date:  2013-02-01

6.  Granulocytic sarcoma (chloroma) presenting as a lateral neck mass: initial manifestation of leukemia: a case report.

Authors:  Young-Hen Lee; Nam-Joon Lee; Eun-Jeong Choi; Jung-Hyuk Kim
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-10-05       Impact factor: 2.503

Review 7.  Isolated Intracranial Myeloid Sarcoma at Age 6 Months with Metastases : Case Report and Review of the Literature.

Authors:  Jianbin Zhu; Sujan Thapa; Xianlong Wang; Chunxiu Jiang; Yaoming Qu; Zhibo Wen
Journal:  Clin Neuroradiol       Date:  2019-04-02       Impact factor: 3.649

8.  Wolf in sheep's clothing: acute chloroma disguised as a subdural hematoma.

Authors:  G M Mallory; J J Van Gompel; A A Rabinstein; J E Fugate; G Lanzino
Journal:  Neurocrit Care       Date:  2012-02       Impact factor: 3.210

9.  Granulocytic Sarcoma in the Head and Neck: CT and MR Imaging Findings.

Authors:  Bong Wan Noh; Sun-Won Park; Jung-Eun Chun; Ji Hye Kim; Hyung Jin Kim; Myung Kwan Lim
Journal:  Clin Exp Otorhinolaryngol       Date:  2009-06-27       Impact factor: 3.372

10.  Acute myelogenous leukemia and acute leukemic appendicitis: a case report.

Authors:  Po-Jen Hsiao; Shih-Ming Kuo; Jia-Hong Chen; Hsuen-Fu Lin; Pau-Ling Chu; Shih-Hua Lin; Ching-Liang Ho
Journal:  World J Gastroenterol       Date:  2009-11-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.